Companies / Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc.
Nasdaq: ORKACIK 907654MENLO PARK, CA
Insider flow · last 90 daysNet sells $51.1K
Financials · FY2023
Ownership
66.2M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 1.67% | 1,108,203 |
| 10%+ / strategic | 8.06% | 5,336,993 |
| Institutions | 74.40% | 49,257,853 |
| Public float | 15.87% | 10,506,650 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 7
View all →| Insider | % of shares | Shares |
|---|---|---|
Klein Lawrence OttoCEOChief Executive Officer · Director | 1.40% | 927,309 |
Sandler Laura LeeFormerChief Operating Officer | 0.36% | 236,984 |
Dambkowski CarlDirector | 0.18% | 116,483 |
Goncalves JoanaChief Medical Officer | 0.05% | 33,377 |
Quinlan Paul TGeneral Counsel | 0.05% | 31,034 |
Agarwal ArjunFormerSenior Vice President, Finance | 0.03% | 18,863 |
Ball Kristine MDirector | — | — |
Institutional holders 160
View all →| Holder | Value | % of shares |
|---|---|---|
| $474.92M | 7.54% | |
| $254.38M | 4.04% | |
| $220.09M | 10.97% | |
| $149.00M | 2.36% | |
| $130.80M | 4.03% | |
| $125.74M | 6.27% | |
| $112.31M | 5.60% | |
| $74.37M | 3.71% | |
| $68.45M | 2.11% | |
| $65.52M | 3.26% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $138.07M | +1.5M +40.99% | 4,990,181 7.54% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $122.69M | +1.3M +93.16% | 2,673,090 4.04% of shares | high |
| Q1 2026 as of | Westfield Capital Management Company, L.P. 13F manager | New | Common stock | $15.36M | +313K | 313,130 0.47% of shares | medium |
| Q2 2026 as of | Victory Capital Management, Inc. 13F manager | Add | Common stock | $11.38M | +120K +2556.65% | 124,278 0.19% of shares | medium |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | New | Common stock | $9.32M | +190K | 190,030 0.29% of shares | medium |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Add | Common stock | $7.22M | +76K +63.58% | 195,204 0.29% of shares | medium |
| Q1 2026 as of | Perceptive Advisors LLC 13F manager | Trim | Common stock | $-3.97M | -81K -5.49% | 1,395,501 2.11% of shares | low |
| Q1 2026 as of | HighVista Strategies LLC 13F manager | New | Common stock | $3.87M | +79K | 78,911 0.12% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Group Inc | Passive13G | — |
| RTW Investments, LP | Passive13G/A | — |
| Deep Track Capital, LP | Passive13G/A | — |
| BlackRock, Inc. | Passive13G | — |
| Viking Global Investors LP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ORKA | — | 687604108 |